";s:4:"text";s:4106:" It is slightly soluble in water, very slightly soluble in methanol, and insoluble in chloroform.Baclofen injection (intrathecal) is a sterile, clear, colorless, pyrogen-free, isotonic solution free of antioxidants, preservatives or other potentially neurotoxic additives indicated only for intrathecal administration. baclofen only if the potential benefit justifies the potential risks to the infant.Children should be of
and initiation of chronic infusion of Baclofen Injection (Intrathecal),
the patient should be monitored closely until it is certain that the patient's
Because of the open, uncontrolled nature of the experience, a causal linkage between events observed and the administration of intrathecal baclofen cannot be reliably assessed in many cases and many of the adverse reactions reported are known to occur in association with the underlying conditions being treated. It may be important to titrate the dose to maintain some degree of muscle tone and allow occasional spasms to: 1) help support circulatory function, 2) possibly prevent the formation of deep vein thrombosis, 3) optimize activities of daily living and ease of care.Except in overdose related emergencies, the dose of Baclofen Injection should ordinarily be reduced slowly if the drug is discontinued for any reason.An attempt should be made to discontinue concomitant oral antispasticity medication to avoid possible overdose or adverse drug interactions, either prior to screening or following implant and initiation of chronic Baclofen Injection infusion. Includes baclofen side effects, interactions and indications. regarding the Cases of intrathecal mass
A sudden
A second patient, a 52 year-old woman with MS and a history of an inferior wall myocardial infarction, was found dead in bed 12 days after pump implantation, 2 hours after having had documented normal vital signs.
Patients with spasticity due to traumatic brain injury should wait at least one year after the injury before consideration of long term intrathecal baclofen therapy. The lowest dose with an optimal response should be used.During long term treatment, approximately 5% (28/627) of patients become refractory to increasing doses. Please consult pump manufacturer's manual for specific recommendations. Baclofen Injection (Intrathecal) is needed when spasticity is necessary to
Use 1.5 mL of 50 mcg/mL Baclofen Injection for a 75 mcg bolus dose. an assessment of the patient's response to bolus Baclofen Injection
intrathecal infusion of intrathecal baclofen to placebo in patients with severe
used with certain implantable pumps. The most frequent symptoms associated with intrathecal mass are: 1) decreased therapeutic response (worsening spasticity, return of spasticity when previously well controlled, withdrawal symptoms, poor response to escalating doses, or frequent or large dosage increases), 2) pain, 3) neurological deficit/dysfunction.Clinicians should monitor patients on intraspinal therapy carefully for any new neurological signs or symptoms. in breast milk of nursing mothers receiving intrathecal baclofen. Very often, the maintenance dose needs to be adjusted during the first few months of therapy while patients adjust to changes in lifestyle due to the alleviation of spasticity. They received intrathecal baclofen for periods of one day (screening) (N=211) to 84 months (maintenance) (N=1).